PDCD1 and lung carcinoma: In agreement with our data, anti–PD-1 treatment of an autochthonous lung cancer mouse model increases IL-17A–producing γδ T cells and CD4+ T cells, which correlates with suppression of cytotoxic CD8+ T cells (Li et al., 2021).